ABT Stock to Gain From Early CE Mark Approval of Volt PFA System
Abbott ABT recently announced CE Mark approval for the Volt Pulsed Field Ablation (“PFA”) system to treat patients battling atrial fibrillation (AFib). The development came earlier than expected, ...
Abbott joins AFib-treating race with tech that may skip general anesthesia
With a key regulatory approval secured in Europe, Abbott Laboratories is joining the race to commercialize technology that ...
Abbott Laboratories (ABT) Receives a Buy from Wells Fargo
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...
Backers of $3B cable designed to carry wind energy now downplay the wind part
Propel NY Energy project promises grid benefits but faces community concerns over electromagnetic fields in public meetings.